Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 57,471 shares at $3.68 ($212K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Seasonal sale ($212k) by President, R&D — this insider has traded RLAY in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.74 | 4,069 | $15K | 7.2% |
| 2 | $3.68 | 26,701 | $98K | 46.4% |
| 3 | $3.68 | 26,701 | $98K | 46.4% |
| Total | $3.68 avg | 57,471 | $212K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |